CBLL - CeriBell EEG Market Value

Public company logo of CeriBell (CBLL)

The market dynamics of CeriBell, Inc. (CBLL) on the GURU.Markets platform show indicators at the level of 1.07. CeriBell, Inc. (CBLL) generates revenue through the supply of consumables for wearable EEG devices, creating a long-term dependency of clinics on its sensors. Demand for AI-driven epilepsy diagnostics remains stable regardless of economic conditions, while growing recognition among intensive care physicians confirms the high value of rapid methods for detecting critical conditions.

CBLL CeriBell: Market Value in the range 10/12/2024 - 11/11/2026
Product sample of ceribell.com

Market capitalization measures the aggregate value of all shares, separating the fundamental trend from short-term noise. Investors assess business resilience by analyzing the issuer's total capitalization as an indicator of institutional confidence. This metric reflects the company's market weight within the medical technology sector. For CeriBell, Inc. (CBLL), this confirms the value of its intellectual property against a backdrop of high production outsourcing. The indicator's dynamics demonstrate asset liquidity given the localization of key algorithms.

Key competitors

Market Capitalization BIIB (Biogen)|Neurocrine - Market Value|RGC - Market Value|AXSM: Market Value|ACADIA Pharmaceuticals (ACAD) - Market Value|XENE (xenon-pharma.com) - Market Value|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Market Value|Market Value Anavex Life Sciences Corp (AVXL)|PRTA (Prothena Corporation PLC) - Market Capitalization|Market Valuation Alector Therapeutics (ALEC)|Market Capitalization ANNX|OMER - Market Value|Market Value Neurogene Corp NGNE|Market Value ACIU|Voyager Therapeutics - Market Capitalization|Market Capitalization neumoratx.com NMRA|SCLX: Market Capitalization|TVGN (Tevogen Bio Holdings Inc.) - Market Value|ACOG (Alpha Cognition Inc) - Market Capitalization|Market Value cogrx.com CGTX|Market Value Inhibikase Therapeutics (IKT)|Market Value SAVA (cassavasciences.com)|Market Value Assertio ASRT|Coya Therapeutics Inc - Market Value|VTGN: Market Valuation|Market Value OVID (Ovid Therapeutics Inc.)|ABOS: Market Capitalization|CRVO - Market Capitalization|Market Value Alterity Therapeutics Ltd.|Market Capitalization CLNN (Clene Nanomedicine)|Market Capitalization PEPG|Market Valuation jupiterneurosciences.com JUNS|Relmada Therapeutics - Market Valuation|Market Capitalization annovisbio.com (ANVS)|Grace Tx - Market Capitalization|Firefly Neuroscience, Inc. (AIFF) - Market Valuation|KLTO: Market Capitalization|NRSN (NeuroSense Therapeutics Ltd.) - Market Value|Market Value Reviva Pharmaceuticals|Market Value MTVA|Market Value NeurAxis (NRXS)|Market Value HSDT (heliusmedical.com)|Market Value Passage Bio PASG|NEUP: Market Capitalization|Minerva Neurosciences - Market Capitalization|Market Value athira.com|ADXN (Addex Therapeutics Ltd) - Market Valuation|Alzamend Neuro (ALZN) - Market Capitalization|Market Value Cyclerion Therapeutics Inc.|PTIX: Market Value|Market Value Pasithea Therapeutics (KTTA)|CRGT - Market Value|Market Capitalization ATXI (Avenue Therapeutics, Inc.)|BCLI - Market Valuation|Cara Therapeutics, Inc - Market Capitalization|Market Value Chromocell|eliemtx.com (ELYM) - Market Value|Intra-Cellular Therapies, Inc. - Market Value|LBPH (Longboard Pharmaceuticals, Inc.) - Market Capitalization|Marinus Pharmaceuticals Inc (MRNS) - Market Capitalization|Market Capitalization NKGN|Market Value NRBO (NeuroBo Pharma)|Market Capitalization SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Market Value|TRVN - Market Value|VIGL: Market Value|Anew Medical, Inc. (WENA) - Market Value|CERE (Cerevel Corp) - Market Value